In the ever-evolving cell therapy landscape, the challenge of potency assay development remains critical. At the 4th Cell ...

Celebrating 10 years as the definitive platform for the NK community, the flagship Innate Killer Summit will unite ...

That increased convenience will have to be accompanied by weight loss that is at least as effective as its rivals, and Amgen ...

In the era of digital health transformation, generative AI (GenAI) has emerged as a breakthrough technology in ...

Just over a month after it was approved in the UK, AstraZeneca and Ionis' Wainzua has been recommended for NHS use in the ...

Medigene has said it will cut 40% of its workforce and delay the start of clinical trials of its lead asset as it re-jigs its ...

Medicare coverage would reduce out-of-pocket costs for AOMs – which can currently be as high as $1,000 a month - by as much ...

Returning for its 15th anniversary year, World ADC London is the leading European conference uniting over 1000 ADC ...

The Swiss pharma group has agreed a $9 per share deal to acquire Poseida, valuing the company at around $1 billion, with another $500 million potentially payable to shareholders in a contingent value ...